Bahr G M, Rook G A, Shahin A, Stanford J L, Sattar M I, Behbehani K
Department of Microbiology, Faculty of Medicine, Kuwait University.
Clin Exp Immunol. 1988 Apr;72(1):26-31.
Using sera from 75 healthy donors, 68 rheumatoid arthritis (RA) patients, and 85 tuberculosis (TB) patients, we have examined the level of antibody of the three major classes binding to seven mycobacterial species, and to three control antigens. The major findings are that IgM binding to mycobacteria is reduced in RA patients who have HLA-DR7 (P = 0.008 for M. tuberculosis antigen), and that IgA binding to mycobacteria is reduced in RA patients who have HLA-DR2 (P = 0.007 for M. tuberculosis; P = 0.0004 for M. nonchromogenicum). These associations were not seen in TB, and were restricted to these antibody isotypes. We believe this is the first report of isotype specific Class II MHC-associated regulation of antibody levels in man. A possible interpretation of our data is that patients bearing these haplotypes are recognizing suppressor epitopes common to all the mycobacterial species tested. Since DR2 and DR7 have recently been shown to be associated with a significantly reduced risk of RA, our findings are compatible with the view that changes in immune responsiveness to mycobacterial antigens, or to autoantigens which cross-react with them, are relevant to RA.
我们使用了75名健康供体、68名类风湿性关节炎(RA)患者和85名结核病(TB)患者的血清,检测了与7种分枝杆菌以及3种对照抗原结合的三大类抗体的水平。主要发现是,携带HLA - DR7的RA患者中,与分枝杆菌结合的IgM减少(结核分枝杆菌抗原的P = 0.008),而携带HLA - DR2的RA患者中,与分枝杆菌结合的IgA减少(结核分枝杆菌的P = 0.007;非产色分枝杆菌的P = 0.0004)。这些关联在结核病患者中未观察到,且仅限于这些抗体同种型。我们认为这是关于人类中II类主要组织相容性复合体(MHC)相关的抗体水平同种型特异性调节的首次报道。对我们数据的一种可能解释是,携带这些单倍型的患者正在识别所有测试分枝杆菌物种共有的抑制性表位。由于最近已表明DR2和DR7与RA风险显著降低相关,我们的发现与以下观点一致,即对分枝杆菌抗原或与其交叉反应的自身抗原的免疫反应性变化与RA有关。